De Boer; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for De Boer; Mark.The latest application filed is for "compositions and methods comprising iga antibody constructs".

Company Profile

1.16.8

De Boer; Mark - Utrecht NL
De Boer; Mark - Westerly RI
De Boer; Mark - Blaricum NL
de Boer; Mark - Beverwyk NL
De Boer; Mark - Cm Utrecht NL
de Boer; Mark - Beverwijk NL
De Boer; Mark - Amersfoort NL
de Boer; Mark - Heemskerk NL
de Boer; Mark - Almere NL
de Boer; Mark - Beverwyle NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antagonistic anti-human CD40 monoclonal antibodies Grant 11,396,552 - Adang , et al. July 26, 2	2022-07-26
COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS App 20210332131 - De Boer; Mark ; et al.	2021-10-28
Antagonistic Anti-human Cd40 Monoclonal Antibodies App 20210101991 - Adang; Anton Egbert Peter ; et al.	2021-04-08
T Cell-based Immunotherapeutics App 20170354681 - De Boer; Mark ; et al.	2017-12-14
CD40 Signalling Inhibitor and a Further Compound, Wherein the Further Compound is a Bile Acid, a Bile Acid Derivative, an TGR5-Receptor Agonist, an FXR Agonist or a Combination Thereof, for the Treatment of Chronic Inflammation, and the Prevention of Gastrointestinal Cancer or Fibrosis App 20160151486 - Adang; Anton Egbert Peter ; et al.	2016-06-02
Gene constructs coding for CD40-binding activating antibodies Grant 7,820,807 - Thomas , et al. October 26, 2	2010-10-26
Anti-CD40 antibodies capable of blocking B-cell activation Grant 7,790,166 - de Boer , et al. September 7, 2	2010-09-07
CD40-binding activating antibodies Grant 7,547,438 - Thomas , et al. June 16, 2	2009-06-16
Anti-cd40 Antibodies Capable Of Blocking B-cell Activation App 20090130095 - de Boer; Mark ; et al.	2009-05-21
Anti-CD40 antibodies capable of blocking B-cell activation Grant 7,361,345 - de Boer , et al. April 22, 2	2008-04-22
Cd40-binding Apc-activating Molecules App 20070098720 - Thomas; David ; et al.	2007-05-03
Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies Grant 7,172,759 - Thomas , et al. February 6, 2	2007-02-06
Method of inducing immune tolerance App 20070009517 - De Boer; Mark ; et al.	2007-01-11
Anti-CD40 antibodies capable of blocking B-cell activation App 20050169923 - de Boer, Mark ; et al.	2005-08-04
Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies Grant 6,899,879 - de Boer , et al. May 31, 2	2005-05-31
Hydroprocessing catalyst and use thereof Grant 6,893,553 - Abe , et al. May 17, 2	2005-05-17
Catalyst comprising at least a hydrogenation metal component and a synthetic clay and a process of using Grant 6,334,947 - De Boer , et al. January 1, 2	2002-01-01
CD40 antigen antibody complex Grant 6,056,959 - de Boer , et al. May 2, 2	2000-05-02
Process for preparing a large pore hydroprocessing catalyst Grant 6,030,915 - de Boer February 29, 2	2000-02-29
Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation Grant 5,874,082 - de Boer February 23, 1	1999-02-23
Methods of blocking T-cell activation using anti-B7 monoclonal antibodies Grant 5,869,050 - de Boer , et al. February 9, 1	1999-02-09
Methods and materials for the induction of T cell anergy Grant 5,747,034 - de Boer , et al. May 5, 1	1998-05-05
Anti-CD40 monoclonal antibodies capable of blocking B-cell activation Grant 5,677,165 - de Boer , et al. October 14, 1	1997-10-14
Method for generation of antibodies to cell surface molecules Grant 5,397,703 - De Boer , et al. March 14, 1	1995-03-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.